Combination of mitoxantrone, topotecan and cytarabine in patients with refractory or relapsed AML or CML in blast crisis.

被引：0

作者：

Hoechsmann, B ^{[1
]}

Döhner, H ^{[1
]}

Ganser, A ^{[1
]}

Heil, G ^{[1
]}

Einsele, H ^{[1
]}

Raghavachar, A ^{[1
]}

Hoelzer, D ^{[1
]}

Bergmann, L ^{[1
]}

机构：

[1] Univ Ulm, Dept Hematol Oncol, Ulm, Germany

来源：

BLOOD | 2000年 / 96卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1402

引用

页码：325A / 325A

页数：1

共 50 条

[31] A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
Vigil, E.
Griffiths, A.
Thompson, E.
Brady, E.
Dickey, M.
Ford, A.
Wang, S.
Wetzler, M.
HAEMATOLOGICA, 2012, 97 : 33 - 33
[32] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
Naqvi, Kiran
Ravandi, Farhad
Kantarjian, Hagop
Borthakur, Gautam
Ferrajoli, Alessandra
Thomas, Deborah A.
Koller, Charles Asa
Konopleva, Marina
Byrd, Anna
Kwari, Monica
Faderl, Stefan
BLOOD, 2010, 116 (21) : 464 - 465
[33] Leukemic stem cell analysis in a mouse model of CML blast crisis.
Echlin-Bell, DR
Sozer, S
Grimes, BA
Sauvageau, G
Jordan, CT
BLOOD, 2002, 100 (11) : 533A - 533A
[34] Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Fludarabine and Cytarabine in Pediatric Patients with Relapsed or Refractory AML
Rubnitz, Jeffrey E.
Kaufman, Ronda
Ribeiro, Raul C.
Klebanov, Boris
Ellis, Joel
Landesman, Yosef
Youssoufian, Hagop
Rashal, Tami
Shacham, Sharon
BLOOD, 2015, 126 (23)
[35] A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
Christian, Sonia
Arain, Saad
Patel, Pritesh
Khan, Irum
Calip, Gregory S.
Agrawal, Vaibhav
Sweiss, Karen
Griffin, Shawn
Cahill, Kirk
Konig, Heiko
Esen, Aysenur
Shergill, Ardaman
Odenike, Olatoyosi
Stock, Wendy
Quigley, John G.
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) : 937 - 943
[36] High Dose Cytarabine, Mitoxantrone and L-Asparaginase (HAMA) Salvage For Relapsed Or Refractory Acute Myeloid Leukemia (AML) In The Elderly
Ahmed, Tamjeed
Holwerda, Scott
Pardee, Timothy
Isom, Scott
Lyerly, Susan
Ellis, Leslie Renee
Manuel, Megan
Dralle, Sarah
Dmitriy, Berenzon
Klepin, Heidi D.
Powell, Bayard L.
BLOOD, 2013, 122 (21)
[37] High dose cytarabine, mitoxantrone and L-asparaginase (HAMA) salvage for relapsed or refractory acute myeloid leukemia (AML) in the elderly
Ahmed, Tamjeed
Holwerda, Scott
Klepin, Heidi D.
Isom, Scott
Ellis, Leslie R.
Lyerly, Susan
Manuel, Megan
Dralle, Sarah
Berenzon, Dmitriy
Powell, Bayard L.
Pardee, Timothy S.
LEUKEMIA RESEARCH, 2015, 39 (09) : 945 - 949
[38] Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia
Liedtke, Michaela
Dunn, Tamara
Dinner, Shira
Coutre, Steven E.
Berubea, Caroline
Gotlib, Jason
Patel, Samit
Medeiros, Bruno
LEUKEMIA RESEARCH, 2014, 38 (12) : 1441 - 1445
[39] NOVEL COMBINATION OF CYCLOPHOSPHAMIDE, TOPOTECAN AND NAXITIMAB FOR RELAPSED REFRACTORY NEUROBLASTOMA
Brown, Lauren
Phillips, Katlin
Michael, Meghan
Oesterheld, Javier
Sholler, Giselle Saulnier
Trovillion, Erin
PEDIATRIC BLOOD & CANCER, 2023, 70 : S114 - S115
[40] APhase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia
Advani, Anjali S.
Cooper, Brenda
Visconte, Valeria
Elson, Paul
Chan, Ricky
Carew, Jennifer
Wei, Wei
Mukherjee, Sudipto
Gerds, Aaron
Carraway, Hetty
Nazha, Aziz
Hamilton, Betty
Sobecks, Ronald
Caimi, Paolo
Tomlinson, Benjamin
Malek, Ehsan
Little, Jane
Miron, Alexander
Pink, John
Maciejewski, Jaroslaw
Unger, Allison
Kalaycio, Matt
de Lima, Marcos
Sekeres, Mikkael A.
CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4231 - 4237

← 1 2 3 4 5 →